Karly C. Sourris

2.5k total citations
34 papers, 1.8k citations indexed

About

Karly C. Sourris is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, Karly C. Sourris has authored 34 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Clinical Biochemistry, 14 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Nephrology. Recurrent topics in Karly C. Sourris's work include Advanced Glycation End Products research (22 papers), Chronic Kidney Disease and Diabetes (10 papers) and Natural Antidiabetic Agents Studies (7 papers). Karly C. Sourris is often cited by papers focused on Advanced Glycation End Products research (22 papers), Chronic Kidney Disease and Diabetes (10 papers) and Natural Antidiabetic Agents Studies (7 papers). Karly C. Sourris collaborates with scholars based in Australia, Germany and United States. Karly C. Sourris's co-authors include Josephine M. Forbes, Mark E. Cooper, Melinda T. Coughlan, Sally A. Penfold, Vicki Thallas‐Bonke, Brooke E. Harcourt, Kei Fukami, Angelika Bierhaus, David R. Thorburn and Adeline Tan and has published in prestigious journals such as Advanced Materials, American Journal of Clinical Nutrition and Diabetes.

In The Last Decade

Karly C. Sourris

33 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karly C. Sourris Australia 19 1.0k 571 498 400 349 34 1.8k
Sally A. Penfold Australia 17 794 0.8× 669 1.2× 590 1.2× 357 0.9× 353 1.0× 24 1.9k
Vicki Thallas‐Bonke Australia 22 1.4k 1.4× 784 1.4× 902 1.8× 861 2.2× 559 1.6× 31 3.0k
Adeline Tan Australia 12 578 0.6× 306 0.5× 292 0.6× 216 0.5× 195 0.6× 17 1.3k
Hank Founds United States 11 905 0.9× 543 1.0× 217 0.4× 175 0.4× 308 0.9× 11 1.4k
Yoshisuke Haruna Japan 17 224 0.2× 227 0.4× 441 0.9× 552 1.4× 350 1.0× 23 1.6k
Koji Kuboki Japan 10 287 0.3× 440 0.8× 505 1.0× 275 0.7× 371 1.1× 22 1.5k
D G Dyer United States 10 1.5k 1.5× 762 1.3× 483 1.0× 130 0.3× 493 1.4× 10 2.1k
Marisa Passarelli Brazil 27 402 0.4× 697 1.2× 469 0.9× 71 0.2× 341 1.0× 105 1.8k
N. Karachalias United Kingdom 9 971 1.0× 547 1.0× 309 0.6× 110 0.3× 421 1.2× 11 1.5k
Thomas Gawlowski Germany 16 601 0.6× 449 0.8× 436 0.9× 49 0.1× 267 0.8× 18 1.4k

Countries citing papers authored by Karly C. Sourris

Since Specialization
Citations

This map shows the geographic impact of Karly C. Sourris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karly C. Sourris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karly C. Sourris more than expected).

Fields of papers citing papers by Karly C. Sourris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karly C. Sourris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karly C. Sourris. The network helps show where Karly C. Sourris may publish in the future.

Co-authorship network of co-authors of Karly C. Sourris

This figure shows the co-authorship network connecting the top 25 collaborators of Karly C. Sourris. A scholar is included among the top collaborators of Karly C. Sourris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karly C. Sourris. Karly C. Sourris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thallas‐Bonke, Vicki, Matthew Snelson, Karly C. Sourris, et al.. (2025). Proximal tubular deletion of superoxide dismutase-2 reveals disparate effects on kidney function in diabetes. Redox Biology. 82. 103601–103601. 1 indexed citations
2.
Hagiwara, Shinji, Jun Okabe, Mark Ziemann, et al.. (2025). miR-214 and Its Primary Transcript Dnm3os Regulate Fibrosis and Inflammation Through RAGE Signaling in Diabetic Kidney Disease. Diabetes. 74(7). 1205–1219. 1 indexed citations
3.
Xu, Rong, Sukhvir Kaur Bhangu, Karly C. Sourris, et al.. (2023). An Engineered Nanosugar Enables Rapid and Sustained Glucose‐Responsive Insulin Delivery in Diabetic Mice. Advanced Materials. 35(21). e2210392–e2210392. 22 indexed citations
4.
Sourris, Karly C., et al.. (2022). Transflection infrared spectroscopy as a rapid screening tool for urinary 8-isoprostane. Microchemical Journal. 181. 107641–107641. 3 indexed citations
5.
Watson, Anna M.D., Sarah C. Moody, Priyadharshini Sivakumaran, et al.. (2020). Disparate Effects of Diabetes and Hyperlipidemia on Experimental Kidney Disease. Frontiers in Physiology. 11. 518–518. 4 indexed citations
6.
Zhuang, Aowen, Felicia Y. T. Yap, Domenica A. McCarthy, et al.. (2019). Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretion. Scientific Reports. 9(1). 13664–13664. 4 indexed citations
7.
Mousa, Aya, Negar Naderpoor, Josphin Johnson, et al.. (2017). Effect of vitamin D supplementation on inflammation and nuclear factor kappa-B activity in overweight/obese adults: a randomized placebo-controlled trial. Scientific Reports. 7(1). 15154–15154. 43 indexed citations
8.
Zhuang, Aowen, Felicia Y. T. Yap, Clinton R. Bruce, et al.. (2017). Increased liver AGEs induce hepatic injury mediated through an OST48 pathway. Scientific Reports. 7(1). 12292–12292. 22 indexed citations
9.
Coughlan, Melinda T., Sally A. Penfold, Gavin C. Higgins, et al.. (2016). Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes. Clinical Science. 130(9). 711–720. 140 indexed citations
10.
Courten, Barbora de, Maximilian de Courten, Georgia Soldatos, et al.. (2016). Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial. American Journal of Clinical Nutrition. 103(6). 1426–1433. 109 indexed citations
11.
Tesch, Greg H., Karly C. Sourris, Shaun A. Summers, et al.. (2014). Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes. Diabetologia. 57(9). 1977–1985. 26 indexed citations
12.
Forbes, Josephine M., Karly C. Sourris, Maximilian de Courten, et al.. (2013). Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects. Amino Acids. 46(2). 321–326. 25 indexed citations
13.
Coughlan, Melinda T., Sheila K. Patel, George Jerums, et al.. (2011). Advanced Glycation Urinary Protein-Bound Biomarkers and Severity of Diabetic Nephropathy in Man. American Journal of Nephrology. 34(4). 347–355. 30 indexed citations
14.
Sourris, Karly C., Brooke E. Harcourt, Peter Tang, et al.. (2011). Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes. Free Radical Biology and Medicine. 52(3). 716–723. 108 indexed citations
15.
Sourris, Karly C., Brooke E. Harcourt, Sally A. Penfold, et al.. (2010). Modulation of the Cellular Expression of Circulating Advanced Glycation End-Product Receptors in Type 2 Diabetic Nephropathy. Experimental Diabetes Research. 2010. 1–9. 18 indexed citations
16.
Penfold, Sally A., Melinda T. Coughlan, Sheila K. Patel, et al.. (2010). Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy. Kidney International. 78(3). 287–295. 67 indexed citations
17.
Sourris, Karly C., Brooke E. Harcourt, & Josephine M. Forbes. (2009). A New Perspective on Therapeutic Inhibition of Advanced Glycation in Diabetic Microvascular Complications: Common Downstream Endpoints Achieved Through Disparate Therapeutic Approaches?. American Journal of Nephrology. 30(4). 323–335. 28 indexed citations
18.
19.
20.
Sourris, Karly C., Josephine M. Forbes, & Mark E. Cooper. (2008). Therapeutic Interruption of Advanced Glycation in Diabetic Nephropathy. Annals of the New York Academy of Sciences. 1126(1). 101–106. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sally A. Penfold Breakdown of academic impact, for papers by Vicki Thallas‐Bonke Breakdown of academic impact, for papers by Adeline Tan Breakdown of academic impact, for papers by Hank Founds Breakdown of academic impact, for papers by Yoshisuke Haruna Breakdown of academic impact, for papers by Koji Kuboki Breakdown of academic impact, for papers by D G Dyer Breakdown of academic impact, for papers by Marisa Passarelli Breakdown of academic impact, for papers by N. Karachalias Breakdown of academic impact, for papers by Thomas Gawlowski
Rankless by CCL
2026